“…Diastolic performance improves after treatment of even mild hypertension and reduces cardiovascular, cerebral, and renal complications by 19% to 35%. Alpha-adrenergic blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers reduce afterload, improve systemic blood flow, and improve perfusion of target organs (Lewis, Hunsicker, Bain, & Rohde, 1993;Rocella Bc Bowler, 1990;Winterkorn, Kupersmith, Wirtschafter, & Forman, 1993), Afierload reduction improves functional capacity of large arteries, presumably by augmenting coronary artery filling, myocardial performance, and vascular wall integrity (Luque-Otero & Fernandez-Pinilla, 1990 (Pfeffer & Pfeffer, 1990). Cardiovascular assessment will determine the choice of peripheral vasodilating drug for each patient.…”